AniLocus
Phase 1Anilocus is a preclinical CRO conducting in vivo studies, behavioral neuroscience, and custom apparatus design for pharmaceutical and biotech companies.
Founded
2020
Focus
Gene TherapyRare Disease
About
Anilocus is a preclinical CRO conducting in vivo studies, behavioral neuroscience, and custom apparatus design for pharmaceutical and biotech companies.
Funding History
1Total raised: $4.5M
Seed$4.5MUndisclosedMar 15, 2023
Company Info
TypePrivate
Founded2020
LocationCambridge, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile